BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9380055)

  • 1. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
    Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
    Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological investigations in patients with head tremor.
    Valls-Solé J; Tolosa ES; Nobbe F; Diéguez E; Muñoz E; Sanz P; Valldeoriola F
    Mov Disord; 1997 Jul; 12(4):576-84. PubMed ID: 9251077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head tremor in cervical dystonia.
    Pal PK; Samii A; Schulzer M; Mak E; Tsui JK
    Can J Neurol Sci; 2000 May; 27(2):137-42. PubMed ID: 10830347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term botulinum toxin efficacy, safety, and immunogenicity.
    Mejia NI; Vuong KD; Jankovic J
    Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
    Comella CL; Shannon KM; Jaglin J
    Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
    Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
    Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse sensory geste in cervical dystonia.
    Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
    Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
    Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
    Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of writer's cramp.
    Behari M
    J Assoc Physicians India; 1999 Jul; 47(7):694-8. PubMed ID: 10778589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.